Pharmalicensing brings you advice, commentary and analysis from industry experts.
This article is based on some of the findings of a research study of social and ethical issues related to the commercial implementation of new technologies undertaken during the preparation of the Nuffield Bioethics Council Report on Genetically-modified Crops - www.nuffieldfoundation.org.
To make any comments on this article, or to ask a question of the author, please contact the publisher. If you would like to submit an article, please contact the editors.
The opinions expressed in the articles published in this section do not necessarily reflect those of Pharmalicensing or UTEK Corporation. No actions including proposals to or agreements with other companies should be taken by any reader without obtaining specific business or legal advice. Neither the publisher nor the authors accept any liability for any actions or activities undertaken by any reader or other third party as a consequence of these articles or for any errors or omissions therein.